A retrospective study of transarterial chemoembolization (TACE) combined with lenvatinib compared with TACE monotherapy for BCLC B2 stage hepatocellular carcinoma

The present study aimed to compare the efficacy and safety of combination therapy with lenvatinib (Len) plus transarterial chemoembolization (TACE) and TACE alone in patients with Barcelona Clinic Liver Cancer (BCLC) B2 stage hepatocellular carcinoma (HCC). A total of 66 patients with BCLC B2 stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Junning, Yan, Shu, Zhang, Guangnian, Yang, Linfeng, Wei, Song, Yi, Pengsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618929/
https://www.ncbi.nlm.nih.gov/pubmed/37920437
http://dx.doi.org/10.3892/ol.2023.14094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618929/
https://www.ncbi.nlm.nih.gov/pubmed/37920437
http://dx.doi.org/10.3892/ol.2023.14094

Ejemplares similares